An experimental vaccine has shown positive results in reducing symptoms of multiple sclerosis in mice. The vaccine targets the immune system, preventing it from attacking the body’s own cells. If successful in humans, this vaccine could potentially be used to treat other autoimmune diseases like type 1 diabetes and coeliac disease.
Multiple sclerosis is an autoimmune condition where the immune system mistakenly attacks the protective coating around nerves, leading to various symptoms including muscle spasms and cognitive difficulties.